Dr. Marlin W. Schul, MD

Dr. Schul practices at Flowers Hospital Breast Health Center in Dothan, Alabama.

Dr. Schul's NPI, 1356300834, was assigned on March 22, 2006. Dr. Schul graduated from Indiana University School Of Medicine in 1992. Dr. Schul holds Florida license ME137749.

Dr. Schul's primary practice is Flowers Hospital Breast Health Center, at 4370 West Main St, Ste 101, Dothan, AL 36305. The practice phone is (334) 671-4908.

Dr. Schul's primary practice is Flowers Hospital Breast Health Center in Dothan, Alabama. Dr. Schul is also affiliated with Flowers Hospital. The medical group on file is American Physician Partners. Dmand AI also links Dr. Schul to 6 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schul practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Schul's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Schul is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Schul's licenses on file in 4 states: Florida, Alabama, Indiana and Illinois.

CMS data shows 393 Medicare services from Dr. Schul across 10 procedure codes in 2024, for 301 Medicare patients. Medicare paid $27,759 for them.

CMS counts 301 Medicare patients who saw Dr. Schul in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schul's median patient age at 69, with 58% women.

In 2024, Dr. Schul wrote 180 Medicare Part D claims for 136 patients. 89% of them were for generic drugs. CMS names the drug for 74 of them, across 4 drugs with 11 or more claims each, at $7,791 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Schul for performance year 2024, reported as part of a group. Dr. Schul accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Schul, published from 2011 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Venous Insufficiency, Saphenous Vein and Varicose Veins. Dr. Schul has published most often in Phlebology. Dr. Schul's most frequent co-authors are Lowell S. Kabnick, MD, Kathleen D. Gibson, MD and Caitlin Whitney Hicks, MD, MS.

Dmand AI links Dr. Schul to 1 clinical trial. Conditions studied include Influenza, Human and Orthomyxoviridae Infections.

CMS Open Payments shows 71 general payments to Dr. Schul from 14 drug and device companies from 2016 to 2025. Education make up the largest share, 52% of the total. AngioDynamics, Inc. paid the most, $5,373. It also lists 3 research payments totaling $5,767 from 2023 to 2024.

Dmand AI lists 1 award for Dr. Schul, most recently Top Abstract Presentation in 2019.

Dr. Schul graduated from Indiana University School Of Medicine in 1992. Dr. Schul is a member of American Vein & Lymphatic Society and American Venous Forum.

Dr. Schul is in network with 14 carriers, including Excellus BlueCross BlueShield, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.